CASI Pharmaceuticals (CASIF) Net Income towards Common Stockholders (2022 - 2025)
CASI Pharmaceuticals (CASIF) posted Net Income towards Common Stockholders of -$48.06 trillion for Q4 2025, compared with -$39.26 trillion a year earlier.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Net Income towards Common Stockholders (2022 - 2025) Analysis & Trends
Since Q1 2022, CASI Pharmaceuticals has reported Net Income towards Common Stockholders for 16 quarters.
- In prior years, CASI Pharmaceuticals' Net Income towards Common Stockholders was -$39.26 trillion in FY2024, -$26.26 trillion in FY2023, -$40.26 trillion in FY2022 and -$37.35 million in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Net Income towards Common Stockholders in data going back to Q1 2022.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was -$10.91 million (Q3 2025), -$13.39 million (Q2 2025) and -$10.75 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | CASI Pharmaceuticals | 2.47 Mn | -18.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -48,058.04 Bn |
| Sep 30, 2025 | -10.91 Mn |
| Jun 30, 2025 | -13.39 Mn |
| Mar 31, 2025 | -10.75 Mn |
| Dec 31, 2024 | -39,257.98 Bn |
| Sep 30, 2024 | -8.44 Mn |
| Jun 30, 2024 | -7.28 Mn |
| Mar 31, 2024 | -9.43 Mn |
| Dec 31, 2023 | -26,258.98 Bn |
| Sep 30, 2023 | -5.24 Mn |
| Jun 30, 2023 | -10.46 Mn |
| Mar 31, 2023 | -6.68 Mn |
| Dec 31, 2022 | -40,256.99 Bn |
| Sep 30, 2022 | -6.08 Mn |
| Jun 30, 2022 | -9.23 Mn |
| Mar 31, 2022 | -9.01 Mn |
API Access
CASI Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();